Sign in to view content

The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections

Kapil Mishra, MD

Video
Published 2021

Related

Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2021
Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020
COVID-19 and Preparedness among Ophthalmologists- International Panel Discussion. Drs. Dan Ting, Olivia Li and Steven Yeh
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020

Category: Socioeconomics

See more